__timestamp | BeiGene, Ltd. | ImmunityBio, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 13035000 | 641000 |
Thursday, January 1, 2015 | 8816000 | 236000 |
Friday, January 1, 2016 | 1070000 | 44000 |
Sunday, January 1, 2017 | 238387000 | 45000 |
Monday, January 1, 2018 | 198220000 | 47000 |
Tuesday, January 1, 2019 | 428212000 | 2202000 |
Wednesday, January 1, 2020 | 308874000 | 605000 |
Friday, January 1, 2021 | 1176283000 | 934000 |
Saturday, January 1, 2022 | 1415921000 | 240000 |
Sunday, January 1, 2023 | 2458779000 | 622000 |
Unleashing the power of data
In the competitive landscape of biotechnology, revenue generation is a key indicator of a company's market position and growth potential. Over the past decade, BeiGene, Ltd. has consistently outperformed ImmunityBio, Inc. in terms of revenue. From 2014 to 2023, BeiGene's revenue surged by an impressive 18,800%, reaching a peak of approximately $2.46 billion in 2023. In contrast, ImmunityBio's revenue growth has been more modest, with a peak of just over $2.2 million in 2019, followed by fluctuations in subsequent years.
This stark contrast highlights BeiGene's strategic advancements and market penetration, particularly in the oncology sector. As the biotech industry continues to evolve, these revenue trends offer valuable insights into the financial health and strategic direction of these two companies. Investors and industry analysts will be keenly watching how these dynamics unfold in the coming years.
Annual Revenue Comparison: Merck & Co., Inc. vs ImmunityBio, Inc.
Revenue Insights: AstraZeneca PLC and ImmunityBio, Inc. Performance Compared
Comparing Revenue Performance: Vertex Pharmaceuticals Incorporated or ImmunityBio, Inc.?
Annual Revenue Comparison: BeiGene, Ltd. vs Viatris Inc.
BeiGene, Ltd. vs Ligand Pharmaceuticals Incorporated: Examining Key Revenue Metrics
Annual Revenue Comparison: BeiGene, Ltd. vs Celldex Therapeutics, Inc.
Revenue Showdown: BeiGene, Ltd. vs BioCryst Pharmaceuticals, Inc.
Revenue Insights: Viatris Inc. and ImmunityBio, Inc. Performance Compared
Bio-Techne Corporation vs ImmunityBio, Inc.: Annual Revenue Growth Compared
Who Generates More Revenue? ADMA Biologics, Inc. or ImmunityBio, Inc.
Annual Revenue Comparison: Veracyte, Inc. vs ImmunityBio, Inc.
Revenue Showdown: Vericel Corporation vs ImmunityBio, Inc.